Doctoral project (P4):

Role of the pro-apoptotic BCL-2 protein BOK in breast Cancer

Further reading:

[1] Weller S, Toennießen A, Schaefer B, Beigl T, Muenchow A, Böpple K, Hofmann U, Gillissen BF, Aulitzky WE, Kopp HG, Essmann F. The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA. Cell Death Discov. 2022 Apr 20;8(1):215. doi: 10.1038/s41420-022-01009-1.

Awards & prices:

N.N.